EMERYVILLE, Calif.,
April 26, 2021 /PRNewswire/ --
Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology
company active in the Clean Health and Beauty markets through its
consumer brands, and a top supplier of sustainable and natural
ingredients, successfully hosted the third webinar in its virtual
investor mini-series themed "Delivering on the Promise of Synthetic
Biology."
This third webinar entitled "Science and Partnerships,
Building Blocks for Disruptive, Natural, Sustainably Sourced
Ingredients" was conducted via live webcast and teleconference
on Thursday, April 22, 2021.
The livestreamed webinar, attended by more than 350 members of
the investor community featured John
Melo, President and Chief Executive Officer; Han Kieftenbeld, Chief Financial Officer;
Eduardo Alvarez, Chief Operating
Officer; Annie Tsong, Senior
Director of Product Innovation; and guest speaker Fernando Galletti De Queiroz, Chief Executive
Officer of Minerva Foods, a new partner of Amyris.
Mr. Melo provided a business update, including a description of
how our commitment to sustainability is driving our Lab-to-Market
capabilities to create unique ingredients for consumer products in
the Clean Health and Beauty markets. The presenters then described
the depth and flexibility of Amyris's technology and how the
Company is helping to transform supply chains, reduce costs and
provide greater access to sustainably sourced ingredients. The
presentation concluded with an overview of the Company's
methodology for advancing molecules from discovery to
commercialization, including its multi-factor development screening
process. During the Q&A panel discussion, Mr. Galletti De
Queiroz highlighted the value he expects Amyris to provide to
Minerva Foods in achieving sustainability objectives.
Presentation materials and a replay of the third virtual
investor mini-series are available in the investor relations
section of Amyris's website at http://investors.amyris.com.
"This event concludes a very successful webinar series
highlighting how Amyris is delivering on the promise of synthetic
biology," commented John Melo,
President and CEO of Amyris. "We are just scratching the surface of
the capabilities of our technology. Clean chemistry and sustainable
consumption will help all of us live better lives, and we look
forward to engaging and educating the public through similar events
in the future."
About Amyris
Amyris (Nasdaq: AMRS) is a science and
technology leader in the research, development and production of
sustainable ingredients for the Clean Health & Beauty and
Flavors & Fragrances markets. Amyris uses an impressive array
of exclusive technologies, including state-of-the-art machine
learning, robotics and artificial intelligence. Our ingredients are
included in over 3,000 products from the world's top brands,
reaching more than 200 million consumers. Amyris is proud to own
and operate a family of consumer brands - all built around its No
Compromise® promise of clean ingredients: Biossance® clean beauty
skincare, Pipette® clean baby skincare and Purecane™, a
zero-calorie sweetener naturally derived from sugarcane. For more
information, please visit http://www.amyris.com.
Amyris, the Amyris logo, No Compromise, Biossance, Pipette, and
Purecane are trademarks or registered trademarks of Amyris, Inc. in
the U.S. and/or other countries.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/amyris-hosts-successful-final-session-of-its-three-part-virtual-mini-series-301276507.html
SOURCE Amyris, Inc.